Cardiac Surgery: Current Treatment and Future Options

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: closed (25 March 2024) | Viewed by 815

Special Issue Editor


E-Mail Website
Guest Editor
Division of Cardiac Surgery, Department of Cardio-Thoracic-Vascular Surgery, University of Messina - Papardo Hospital, Messina, Italy
Interests: minimally invasive cardiac surgery; transcatheter mitral valve repair; transcatheter aortic valve implantation; neochord for mital valve repair; minimally invasive surgical aortic valve replacement

Special Issue Information

Dear Colleagues,

Recent years have been marked by a high and consistent capacity for innovation and diversification of health care technologies, bringing positive results for health and quality of life, but, at the same time, contributing significantly to increasing health care costs.

However, the introduction of innovative technologies makes it possible to maintain the high quality of services and care by ensuring potential benefits to all.

Currently, the treatment of valvulopathies has shifted toward more minimally invasive surgical and endovascular techniques that make patient recovery faster, thus reducing health care costs.

The proposed collection "Current Treatment and Future Options" will include a selection of research papers by experts in the field of minimally invasive cardiac surgery on valvulopathies, detailing various aspects for basic, clinical and translational research that can be applied to the diagnosis and treatment of various valvulopathies. The collection is aimed to be a concise but comprehensive work that will help surgeons in training as well as experienced practitioners in their daily practice, providing up-to-date evidence on the topic of diagnosis and management of valvulopathies.

Dr. Francesco Patané
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • minimally invasive cardiac surgery
  • transcatheter mitral valve repair
  • transcatheter aortic valve implantation
  • neochord for mital valve repair
  • minimally invasive surgical aortic valve replacement

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 1113 KiB  
Article
Aortic Valve Replacement: Totally Endoscopic versus Mini-Sternotomy
by Alaaddin Yilmaz, Jade Claessens, Loren Packlé, Silke Van Genechten, Kübra Dönmez, Camille Awouters and Lieven Herbots
J. Clin. Med. 2023, 12(23), 7300; https://doi.org/10.3390/jcm12237300 - 24 Nov 2023
Viewed by 570
Abstract
(1) Background: The development of totally endoscopic aortic valve replacement has the potential to enhance clinical results compared to mini-sternotomy. To our knowledge, no comparison between these two techniques has been conducted before. Therefore, the objective of this retrospective study is to examine [...] Read more.
(1) Background: The development of totally endoscopic aortic valve replacement has the potential to enhance clinical results compared to mini-sternotomy. To our knowledge, no comparison between these two techniques has been conducted before. Therefore, the objective of this retrospective study is to examine the results after both totally endoscopic and mini-sternotomy approaches. (2) Methods: This study covered all elective patients who underwent isolated aortic valve replacement, either totally endoscopically (n = 392) or through a mini-sternotomy (n = 323), between 2013 and 2021. Multivariable analysis was used to account for baseline variations between the two groups. All data were retrospectively gathered and analysed. The primary objective of this study was the one-year mortality rate. (3) Results: The mean aortic cross-clamping and cardiopulmonary bypass times were significantly longer in the totally endoscopic approach (cross-clamping: 43.73 ± 13.71 min and 61.93 ± 16.76 min, p-value < 0.001; CPB time: 64.86 ± 23.02 min and 93.23 ± 23.67 min, p-value < 0.001). However, perioperative bleeding was lower (706.40 ± 542.77 mL and 444.50 ± 515.84 mL, p-value < 0.001). The primary objective, one-year survival, did not significantly differ between both groups (Mini-AVR: 94.5% vs TEAVR: 93.3%, p-value = 0.520). (4) Conclusions: Our results show that totally endoscopic aortic valve replacement has comparable clinical results compared to aortic valve replacement through mini-sternotomy. Full article
(This article belongs to the Special Issue Cardiac Surgery: Current Treatment and Future Options)
Show Figures

Figure 1

Back to TopTop